Diurex
- Product NDC
- 52389-306
- 11-digit product format
- 523890306
- Labeler code
- 52389
- Product ID
- 52389-306_32732994-0e5d-93a9-e063-6394a90a9c50
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Caffeine, magnesium salicylate
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- Kobayashi Healthcare International, Inc.
- Application
- M027
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2005-05-15
- Substance
- MAGNESIUM SALICYLATE; CAFFEINE
- Active strength
- 162.5; 50 mg/1; mg/1
- Pharmacologic classes
- Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 52389-306 | 52389-306-21 | D | Discontinued by firm | 2026-10-12 | |
| excluded package | package | 52389-306 | 52389-306-22 | D | Discontinued by firm | 2026-10-12 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 52389-306-21 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 52389-306-22 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 52389-306-21 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 52389-306-22 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 52389-306-21 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 52389-306-22 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 52389-306-21 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 52389-306-22 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 52389-306-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 52389-306-22 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 52389-306-21 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 52389-306-22 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 52389-306-21 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 52389-306-22 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 52389-306-21 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 52389-306-22 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 52389-306-21 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 52389-306-22 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 52389-306-21 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 52389-306-22 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 52389-306-21 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 52389-306-22 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 52389-306-21 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 52389-306-22 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Diurex
- Brand name suffix
- Water Pills
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| MAGNESIUM SALICYLATE | 162.5 mg/1 |
| CAFFEINE | 50 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 41728CY7UX | Internal UNII lookup |
| 3G6A5W338E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1001437 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| e02a39f9-1c8c-4d38-b394-3f5b7062932c | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 7dea7767-9f52-b60a-5435-33cb9cc28bae | Product name | 4 | 20250124 |
| 6338270f-96cb-0ecb-6fbb-0a9bc78001f4 | Product name | 7 | 20250116 |
| 0ca83774-3f79-b837-5d6f-c210102f3bc8 | Product name | 6 | 20250114 |
| 41b814f3-0166-1c53-c9ef-a0794c7daf9d | Product name | 3 | 20221110 |
| a590be26-846c-8659-a5a1-fb25907965dc | Product name | 2 | 20221110 |
| 2dc76302-91c0-4c35-ad78-99adfb049c4b | Product name | 1 | 20200603 |
| e6065d4b-5ae1-476f-a40e-f2851cbb5d2b | Product name | 2 | 20180221 |
| f212291f-05fe-9603-fc7e-bd73e38ce1e6 | Product name | 2 | 20161129 |
| 182f9ab4-4ab5-c449-200f-87ce2ce8e550 | Product name | 2 | 20151105 |
| 332e86c3-7875-ca6e-f934-2206d2b31996 | Product name | 1 | 20140508 |
| 56625fcc-aa34-9d30-d0e9-1c1beb37ea21 | Product name | 1 | 20140508 |
| 7dfac40f-a405-cd2e-7c06-3059ec0e1092 | Product name | 1 | 20140508 |
| 96c2be53-8e44-452d-56a2-d255b2f1af2d | Product name | 1 | 20140508 |
| bf8bd5f7-495f-4022-2780-7ded7ea7ea44 | Product name | 1 | 20140508 |
| d223c173-c39b-d764-47d4-d671d3088815 | Product name | 1 | 20140508 |
| e01133ad-4dcd-c7f3-454b-2ff569ee160a | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52389-306-01 | DiurexWater Pills | 42 in 1 BLISTER PACK | TABLET, COATED | 42 | 13 | |
| 52389-306-02 | DiurexWater Pills | 11 in 1 BLISTER PACK | TABLET, COATED | 11 | 13 | |
| 52389-306-21 | DiurexWater Pills | 2 in 1 CARTON | TABLET, COATED | 2 | 13 | |
| 52389-306-21 | DiurexWater Pills | 21 in 1 BLISTER PACK | TABLET, COATED | 21 | 13 | |
| 52389-306-22 | DiurexWater Pills | 2 in 1 CARTON | TABLET, COATED | 2 | 13 | |
| 52389-306-36 | DiurexWater Pills | 2 in 1 CARTON | TABLET, COATED | 2 | 13 | |
| 52389-306-36 | DiurexWater Pills | 18 in 1 BLISTER PACK | TABLET, COATED | 18 | 13 | |
| 52389-306-42 | DiurexWater Pills | 1 in 1 CARTON | TABLET, COATED | 1 | 13 | |
| 52389-306-84 | DiurexWater Pills | 2 in 1 CARTON | TABLET, COATED | 2 | 13 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Menstrual Complete | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Discount Drug Mart | ba64c29d-4a50-47b7-be6b-6cf7db11a97a | 2026-02-03 | Warnings | M027 |
| Menstrual Relief | ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE | DOLGENCORP, LLC | 89eb8196-54c6-4e30-8655-502cc4313c8a | 2026-02-02 | Warnings | M027 |
| Pamabrom | PAMABROM | Softgel Healthcare Pvt Ltd | 186805ed-84fc-e723-e063-6294a90ad320 | 2026-01-27 | Warnings | M027 |
| Menstrual Complete Pain Relief | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Walgreen Company | 210efe01-3cf4-404c-84b0-314615467ace | 2026-01-20 | Warnings | M027 |
| Menstrual Pain Relief | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Walgreen Company | 3916230c-39e5-4f64-aa0b-b090b000ec35 | 2026-01-20 | Warnings | M027 |
| Menstrual Relief | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Walgreen Company | fc258e1f-5447-421a-84a8-2d9e72fd6099 | 2026-01-20 | Warnings | M027 |
| Thompson Cramp Relief | ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE | Thompson Safety | e82f607d-05b1-2c50-e053-2995a90a607e | 2026-01-08 | Warnings | M027 |
| Menstrual Relief Maximum Strength | ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE | Family Dollar Services Inc | e7e49ebb-4df4-420e-9b9d-74ee70754487 | 2026-01-07 | Warnings | M027 |
| Pamprin Bloat | PAMABROM | Focus Consumer Healthcare, LLC | 42f1846d-2d57-5221-e063-6394a90a3a9f | 2025-12-31 | Warnings | M027 |
| Menstrual Complete | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | WinCo Foods, LLC | 860c4e94-1d1a-4f74-a14a-35f86f4523c4 | 2025-12-11 | Warnings | M027 |
| Midol Bloat Relief | PAMABROM | Bayer HealthCare LLC. | c1ad6073-63f6-669f-e053-2995a90aacee | 2025-12-04 | Warnings | M027 |
| Midol Complete Caffeine Free | ACETAMINOPHEN, CAFFEINE, AND PYRILAMINE MALEATE | Bayer HealthCare LLC. | 177d78c7-871c-cb39-e063-6394a90aab24 | 2025-12-04 | Warnings | M027 |
| Midol Complete Gelcaps | MIDOL COMPLETE | Bayer HealthCare LLC | 0a4477ce-0a02-197d-e054-00144ff88e88 | 2025-12-04 | Warnings | M027 |
| Menstrual Complete | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Chain Drug Marketing Association, Inc. | 5f8f9644-48c5-4556-a0a4-7bdc9a629daa | 2025-11-15 | Warnings | M027 |
| Medi First Plus PMS Relief | ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE | Unifirst First Aid Corporation | e84007e7-498d-4662-e053-2995a90ad4de | 2025-09-09 | Warnings | M027 |
| Green Guard Cramp Relief | ACETAMINOPHEN, PAMABROM, PYRILAMINE MALEATE | Unifirst First Aid Corporation | e6edff0f-94e4-7eba-e053-2a95a90a1d57 | 2025-09-08 | Warnings | M027 |
| Menstrual Complete | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | L.N.K. International, Inc. | c4a28f8f-030d-4487-b74f-13998482e72d | 2025-08-18 | Warnings | M027 |
| RIGHT REMEDIES Maximum Strength Diuretic | PAMABROM | Strive Pharmaceuticals Inc. | 2d6492e0-1c16-6e3a-e063-6294a90a2440 | 2025-05-07 | Warnings | M027 |
| Diurex Ultra | CAFFEINE | Kobayashi Healthcare International, Inc. | 9a035265-40c6-43f5-8de6-6bece8449840 | 2025-04-14 | Warnings | M027 |
| Diurex Max | PAMABROM | Kobayashi Healthcare International, Inc. | 37dfece3-d570-4ab2-ba95-af6eb1f3acd4 | 2025-04-11 | Warnings | M027 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1001437 | caffeine 50 MG / magnesium salicylate 162.5 MG Oral Tablet | PSN | e02a39f9-1c8c-4d38-b394-3f5b7062932c | 13 |
| 1001437 | caffeine 50 MG / magnesium salicylate 162.5 MG Oral Tablet | SCD | e02a39f9-1c8c-4d38-b394-3f5b7062932c | 13 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 52389-306-01 | 52389030601 | 42 in 1 BLISTER PACK | Historical | |||||
| 52389-306-02 | 52389030602 | 11 in 1 BLISTER PACK | Historical | |||||
| 52389-306-21 | 52389030621 | 2 in 1 CARTON | Historical | |||||
| 52389-306-22 | 52389030622 | 2 in 1 CARTON | Historical | |||||
| 52389-306-36 | 52389030636 | 2 BLISTER PACK in 1 CARTON (52389-306-36) / 18 TABLET, COATED in 1 BLISTER PACK | 2 blister pack | 2020-02-14 | 0000-00-00 | No | No | Current |
| 52389-306-42 | 52389030642 | 1 BLISTER PACK in 1 CARTON (52389-306-42) / 42 TABLET, COATED in 1 BLISTER PACK (52389-306-01) | 1 blister pack | 2005-05-15 | 0000-00-00 | No | No | Current |
| 52389-306-84 | 52389030684 | 2 BLISTER PACK in 1 CARTON (52389-306-84) / 42 TABLET, COATED in 1 BLISTER PACK (52389-306-01) | 2 blister pack | 2012-05-02 | 0000-00-00 | No | No | Current |